United States
Home Depot maintains full-year forecast even as it misses on earnings for second straight quarter
General view of a Home Depot store in Midtown Manhattan on February 26, 2025 in New York City. Eduardo Munoz Alvarez | Corbis News | Getty Images Home Depot stuck by its full-year outlook on Tuesday, even as the company came in slightly shy of Wall Street’s expectations for quarterly earnings and revenue. The home […]
Read More
Trump promised Ukraine ‘security guarantees’: Here’s what they could look like
U.S. President Donald Trump greets Ukrainian President Volodymyr Zelenskyy at the White House, amid negotiations to end the Russian war in Ukraine, in Washington, D.C., U.S., August 18, 2025. Kevin Lamarque | Reuters On the face of it, talks on Monday between U.S. President Donald Trump and Ukraine’s President Volodymyr Zelenskyy and European leaders went […]
Read More
CNBC Daily Open: OpenAI CEO, who sparked AI frenzy, worries about AI bubble
Sam Altman, CEO of OpenAI, speaks during the Federal Reserve Integrated Review of the Capital Framework for Large Banks Conference in Washington, D.C, U.S., on July 22, 2025. Al Drago | Bloomberg | Getty Images There’s a bubble forming in the artificial intelligence industry, according to OpenAI CEO Sam Altman. “Are we in a phase […]
Read More
European markets set to open higher amid positive reaction to Trump-Zelenskyy talks
LONDON — European stocks are expected to open broadly higher on Tuesday as global markets reacted positively to the outcome of talks between U.S. President Donald Trump, Ukrainian President Volodymyr Zelenskyy and European leaders at the White House on Monday. The U.K.’s FTSE index is seen opening 0.18% higher, Germany’s DAX 0.14% higher, France’s CAC 40 up 0.16% and Italy’s […]
Read More
CNBC Daily Open: Is the AI industry in a bubble, as OpenAI CEO says?
Sam Altman, CEO of OpenAI, and Lisa Su, CEO of Advanced Micro Devices, testify during the Senate Commerce, Science and Transportation Committee hearing titled “Winning the AI Race: Strengthening U.S. Capabilities in Computing and Innovation,” in Hart building on Thursday, May 8, 2025. Tom Williams | CQ-Roll Call, Inc. | Getty Images There’s a bubble […]
Read More
Stock futures are flat as the market awaits Fed’s Jackson Hole summit, retail earnings: Live updates
SoftBank will invest $2 billion into Intel, chipmaker’s shares rise Japanese conglomerate SoftBank will invest $2 billion into Intel, according to an announcement from the two companies. SoftBank will pay $23 per share of Intel’s common stock. The chipmaker’s shares ended Monday’s regular session at $23.66. Intel jumped more than 5% in extended trading. Stock […]
Read More
How retail accounting could distort profitability as tariffs take effect
As more tariffs take effect on goods imported into the U.S., a specific accounting method could have major implications for how American retailers calculate the impact. A tariff adds to the cost of an imported item when it’s received and paid for when it crosses a border. While there’s debate over who pays that tariff — […]
Read More
Stocks making the biggest moves midday: Meta Platforms, Duolingo, Target, Dayforce, TeraWulf and more
Check out some of the companies making the biggest moves midday: Meta Platforms — The parent of Instagram and Facebook is planning the fourth overhaul of its artificial intelligence operations in six months , The Information reported late Friday, according to Reuters. Meta fell nearly 3% Monday. TeraWulf — The bitcoin miner and AI computing […]
Read More
Investors looking beyond the U.S. see opportunities in one small pocket of Europe
European markets have seen a resurgence this year, with multiple regional indexes outperforming their Wall Street rivals. Amid a broad push to diversify portfolios away from the U.S., some traders see an “unmatched advantage” and “really good investment opportunities” in particular area of Europe. Earlier this year, volatility arising from U.S. President Donald Trump’s unpredictable […]
Read More
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price, as drugmakers face mounting political pressure to lower prices in […]
Read More